How does NAD+ control metabolism and aging?
NAD+ acts as a signal of the cell’s energy state: when energy runs low, NAD+ rises and switches on enzymes called sirtuins, which reshape metabolism. That is the central point of this Endocrine Reviews paper by Houtkooper, Cantó, Wanders and Auwerx. NAD+ is no longer seen only as a helper molecule in energy reactions. It is also used up by several enzyme families, and the balance between making and consuming it links diet, stress and DNA damage to how cells run.
NAD+ was first discovered more than a century ago as “cozymase,” a cofactor in fermentation, and Otto Warburg’s work in the 1930s established what it does in enzyme reactions. Its “secret life” as a signaling molecule came to light much later, and interest has grown because the pathways it controls are tied to oxidative metabolism and to longer life span in animal studies.
What the review covers:
- Metabolic sensor: Sirtuins need relatively high NAD+ levels to work, which makes them sensors of NAD+ and of the cell’s energy status
- Energy stress raises NAD+: Fasting, exercise and low glucose increase NAD+ and activate SIRT1, and in fasted liver NAD+ levels are 50% higher than normal
- NAD+ consumers: PARPs, which repair DNA, and CD38 use up large amounts of NAD+, so their activity can limit how much is left for sirtuins
- Therapeutic interest: Drugs that raise or lower NAD+ or act on sirtuins are being tested for metabolic disease, and the NAD+ synthesis blocker FK866 has entered clinical cancer trials
Dr. Kumar’s Take
The shift here is from thinking of NAD+ as plumbing to thinking of it as a messenger. Fasting and exercise raise NAD+, NAD+ switches on sirtuins, and sirtuins adjust how the body burns fuel. That gives a molecular thread connecting everyday behaviors to cell metabolism. The same review is also honest about the limits: most of the strongest evidence comes from yeast, worms, flies and mice, the sirtuins do not all act the same way, and raising NAD+ is not a simple on switch for health.
NAD+ as a Metabolic Control System
NAD+ has a long-known role as a cofactor that carries electrons in the reactions that break down fuel and build new molecules. The review describes how it has also become a substrate, something enzymes consume, for a wide range of proteins.
Sirtuin activation is the best-studied way NAD+ exerts control. Sirtuins are NAD+-dependent deacetylases. Unlike other NAD+ consumers, they need elevated NAD+ levels to increase their activity, which is why they can act as metabolic NAD+ sensors. SIRT1 is activated in situations of energy stress, such as fasting, exercise or low glucose availability, all of which raise NAD+ inside cells.
Metabolic sensing comes from the balance between NAD+ and its reduced form, NADH. That balance reflects the cell’s redox state, so NAD+ provides a direct link between the cell’s energy status and signaling and gene expression.
Compartmentalized control adds another layer. The nucleus, cytosol and mitochondria keep distinct NAD+ pools, and mitochondrial NAD+ rises with fasting. The authors note that knowledge of how these pools are regulated is still very limited.
The NAD+ Consumers
PARPs attach chains of ADP-ribose to proteins, mainly to help repair DNA and relax chromatin. PARP1 and PARP2 account for virtually all PARP activity in the cell, and heavy PARP activity can drain NAD+.
CD38 and related enzymes also consume NAD+ in large amounts. Because PARPs and CD38 compete with sirtuins for the same pool, reducing their activity can raise NAD+ and indirectly activate sirtuins.
Opposing roles are part of the picture. PARP activity is linked to loosening chromatin for DNA repair and gene expression, while sirtuin action on histones is usually linked to gene silencing.
Therapeutic Implications
The review lays out several ways NAD+ metabolism could be targeted, while stressing that the mechanisms are complicated.
Sirtuin activators have shown effects in mice. Resveratrol activated SIRT1 and prevented diet-induced obesity and related metabolic disease in mice, but the dose used, 400 mg/kg per day, would be about 30 grams a day for a 75 kg person. More specific compounds such as SRT1720 had similar effects on type 2 diabetes in animals at lower doses.
NAD+ synthesis blockers are being explored for cancer. The NAMPT inhibitor FK866 is being tested in clinical cancer trials. The authors point out that both lowering NAD+ and raising NAD+ with SIRT1 activation have been linked to antitumor effects, which shows how complicated these pathways are, and that blocking NAD+ synthesis could also harm healthy tissue.
Aging research drives much of the interest. In yeast, extra copies of the sirtuin gene Sir2 extended life span by 30%, while deleting it cut life span by 50%, and worms and flies with extra copies of Sir2 relatives also lived longer.
Future Directions
The authors call for more work on how NAD+ is distributed inside cells, how different sirtuins are regulated, and what long-term changes in NAD+ metabolism do across the whole body. They see promise in NAD+-based approaches for preventing and treating metabolic disease, but stress that more research is needed before those approaches reach patients.
Related Studies and Research
- Why Do Cancer Cells Choose Inefficient Energy Production?
- Can the Warburg Effect Be Targeted to Treat Cancer?
- The Vitamin C Paradox: Beyond Scurvy to Cancer Treatment
FAQs
How does NAD+ control cellular metabolism?
NAD+ is consumed by sirtuins, which remove acetyl groups from proteins that control metabolism and gene expression. Because sirtuins need relatively high NAD+ to work, their activity tracks the cell’s energy state: when NAD+ rises during fasting or exercise, sirtuins become more active.
Why do fasting and exercise matter for NAD+?
According to this review, fasting, exercise and low glucose availability all increase NAD+ levels inside cells and activate SIRT1. In fasted liver, NAD+ levels were 50% higher than in fed conditions.
What uses up NAD+?
PARPs, which help repair DNA, and CD38 consume large amounts of NAD+. When these enzymes are very active, less NAD+ is left for sirtuins, and when their activity falls, NAD+ can rise.
Is NAD+ relevant to cancer?
The review notes that the NAD+ synthesis blocker FK866 is being tested in clinical cancer trials, and that some sirtuins behave like tumor suppressors. It also warns that both lowering and raising NAD+ have been linked to antitumor effects, so the relationship is not simple.
Does resveratrol raise sirtuin activity in people?
Resveratrol activated SIRT1 in mice, but at a dose equal to roughly 30 grams a day for an average adult, which is far beyond what anyone would take. That is one reason researchers turned to more specific compounds.
Bottom Line
NAD+ is not just an energy cofactor. This review shows how its levels respond to fasting, exercise and cell stress, switch sirtuins on and off, and are drained by DNA-repair and other enzymes. That makes NAD+ a link between lifestyle, metabolism and aging, and a target for drugs being tested in metabolic disease and cancer. Much of the evidence still comes from yeast, worms and mice, so the human payoff remains to be shown.
